Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.53
-0.30 (-4.39%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Verrica Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
11213363308113252
Upgrade
Market Cap Growth
152.50%109.60%-79.41%172.47%-55.17%-15.33%
Upgrade
Enterprise Value
841488826775216
Upgrade
Last Close Price
6.538.317.0073.2027.5091.60
Upgrade
PS Ratio
3.153.748.3860.0912.5121.01
Upgrade
PB Ratio
4.535.37-6.4315.582.827.73
Upgrade
P/TBV Ratio
4.535.37-15.582.827.73
Upgrade
EV/Sales Ratio
2.354.1511.5752.198.3217.98
Upgrade
Debt / Equity Ratio
0.070.07-4.662.300.041.33
Upgrade
Net Debt / Equity Ratio
-1.15-1.150.04-1.22-0.82-0.83
Upgrade
Net Debt / EBITDA Ratio
2.492.490.010.381.570.88
Upgrade
Net Debt / FCF Ratio
1.621.620.010.621.730.95
Upgrade
Asset Turnover
0.700.700.110.080.140.16
Upgrade
Inventory Turnover
5.235.238.37---
Upgrade
Quick Ratio
2.162.161.604.3510.051.53
Upgrade
Current Ratio
2.592.591.764.5511.311.61
Upgrade
Return on Equity (ROE)
-240.36%-240.36%-1546.58%-224.08%-67.42%-106.97%
Upgrade
Return on Assets (ROA)
-14.74%-14.74%-60.63%-62.56%-21.32%-25.04%
Upgrade
Return on Capital Employed (ROCE)
-38.90%-38.90%-262.10%-97.90%-51.60%-90.70%
Upgrade
Earnings Yield
-15.94%-13.46%-120.80%-21.76%-21.67%-13.92%
Upgrade
FCF Yield
-15.71%-13.27%-96.15%-12.65%-16.77%-11.29%
Upgrade
Buyback Yield / Dilution
-105.61%-105.61%-14.26%-32.72%-26.32%-8.20%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.